Waverly Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Buy
+6,069
New +$193K ﹤0.01% 1504
2024
Q4
– Sell
-31,428
Closed -$805K – 984
2024
Q3
$805K Sell
31,428
-1,826
-5% -$46.5K 0.01% 487
2024
Q2
$781K Sell
33,254
-562
-2% -$14.2K 0.02% 479
2024
Q1
$973K Hold
33,816
– – 0.02% 374
2023
Q4
$1.11M Hold
33,816
– – 0.04% 208
2023
Q3
$942K Sell
33,816
-859
-2% -$28.1K 0.04% 204
2023
Q2
$1.18M Buy
34,675
+4,825
+16% +$152K 0.05% 171
2023
Q1
$898K Buy
29,850
+2,700
+10% +$83.7K 0.05% 150
2022
Q4
$766K Sell
27,150
-791
-3% -$25.1K 0.04% 144
2022
Q3
$918K Buy
27,941
+9,142
+49% +$336K 0.06% 116
2022
Q2
$592K Sell
18,799
-3,760
-17% -$131K 0.05% 118
2022
Q1
$1.04M Hold
22,559
– – 0.09% 77
2021
Q4
$1.09M Hold
22,559
– – 0.09% 75
2021
Q3
$1.66M Buy
22,559
+15,989
+243% +$1.34M 0.14% 57
2021
Q2
$530K Hold
6,570
– – 0.05% 109
2021
Q1
$518K Sell
6,570
-155
-2% -$15.4K 0.05% 100
2020
Q4
$746K Sell
6,725
-1,375
-17% -$110K 0.08% 76
2020
Q3
$532K Hold
8,100
– – 0.07% 83
2020
Q2
$481K Hold
8,100
– – 0.06% 88
2020
Q1
$253K Hold
8,100
– – 0.04% 114
2019
Q4
$286K Hold
8,100
– – 0.04% 112
2019
Q3
$239K Hold
8,100
– – 0.03% 116
2019
Q2
$279K Buy
+8,100
New +$260K 0.04% 106

Other funds holding ARKG

Waverly Advisors's ARKG Position: Q2 2026 in Review

Waverly Advisors opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 6,069 shares worth $255K. The stake represents ﹤0.01% of the portfolio and ranks #1504 among its holdings. This is a return to the name: Waverly Advisors previously reported a position in ARKG as recently as Q3 2024.

Waverly Advisors first reported a position in ARKG in Q2 2019 and has held it in 23 quarters since. The position peaked at $1.66M in Q3 2021. 274 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Waverly Advisors held 6,069 shares of ARK Genomic Revolution ETF worth $255K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Waverly Advisors position in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Waverly Advisors's portfolio in Q2 2026, its #1504 holding.
  • Waverly Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2019 and has held it in 23 quarters since.
  • Waverly Advisors's ARK Genomic Revolution ETF position peaked at $1.66M in Q3 2021.
  • 274 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.